Report : South & Central America Colorectal Procedure Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Endoscopes, Electrosurgery Devices, Handheld Devices & Visual Systems, Sealing & Stapling Devices, Ligation Clips and Dilators & Speculas, Cutters and Shears, Accessories, and Others), Surgery Type (Right Hemicolectomy, Left Hemicolectomy, Subtotal Colectomy, Low Anterior Resection, Abdomino-Perineal Resection, and Others), End User (Hospitals & Clinics, Surgery Centers, and Others), and Indication (Colon Polyps, Crohn's Disease, Colorectal Cancer, Colitis, Irritable Bowel Syndrome, and Other Indications)

At 13.6% CAGR, the South & Central America Colorectal Procedure market is speculated to be worth US$ 1,427.31 million by 2028, says Business Market Insights 

According to Business Market Insights’ research, the South & Central America colorectal procedure market was valued at US$ 664.91 million in 2022 and is expected to reach US$ 1,427.31 million by 2028, registering an annual growth rate of 13.6% from 2022 to 2028. Increasing prevalence of colorectal cancer and new product launches are the critical factors attributed to the market expansion.  

Colorectal surgery causes pain, swelling, and scars. In addition, scars from the surgery do not disappear completely. With every surgery, there is also a chance of complications. These complications include major blood loss infection, heart attack, and blood clots. There can also be an injury to nearby organs. Moreover, there are short and long-term side effects specific to colectomy. Further, it has been observed that in the days or weeks following colon resection, food, digested debris, or stool may leak out where the colon was reconnected. This complication is known as an anastomotic leak. This can further cause pain, fever, and life-threatening infection. It is common for scar tissue to form after abdominal surgery. In various cases, as there is so much scar tissue that the bowel becomes obstructed. In rare cases, the bowel may become tightly wrapped around an area of scar tissue. Moreover, the hernia is one of the long-term effects of colon surgery.

Additionally, colonic dilation has been used to treat benign strictures at surgical anastomoses and those associated with Crohn’s disease. Furthermore, two prospective studies with 42 patients with anastomotic strictures not from Crohn’s disease reported no complications after dilations. In contrast, a systematic review of 13 studies with 347 patients with Crohn’s disease with colonic strictures reported dilation-related complications rates of 0% to 18%, with a pooled complication rate of 2%. All complications were associated with perforations. These are some of the factors, which hamper the overall colorectal procedural market growth.

On the contrary, complications associated with colorectal procedure hurdles the growth of South & Central America colorectal procedure market.

  • Based on product, the market is divided into endoscopes, electrosurgery devices, handheld devices and visual systems, sealing and stapling devices, ligation clips and dilators & speculas, cutters and shears, accessories, and others. Endoscpoe segment held 40.8% market share in 2022, amassing US$ 271.20 million. It is projected to garner US$ 586.94 million by 2028 to expand at 13.7% CAGR during 2022–2028.    

In terms of surgery type, the South & Central America colorectal procedure market is segmented into right hemicolectomy, left hemicolectomy, subtotal colectomy, low anterior resection, abdomino-perineal resection, and others (endoscopic surgery). Subtotal colectomy held 62.4% market share in 2022, amassing US$ 415.14 million. It is projected to garner US$ 897.98 million by 2028 to expand at 13.7% CAGR during 2022–2028.

The South & Central America colorectal procedure market, based on end user, is segmented into hospitals and clinics, surgery centers, and others. Hospitals and clinics held 58.7% market share in 2022, amassing US$ 390.40 million. It is projected to garner US$ 826.09 million by 2028 to expand at 13.3% CAGR during 2022–2028.

  • Based on indication, the market is segmented into colon polyps, Crohn's disease, colorectal cancer, colitis, irritable bowel syndrome, and other indications. With 43.7% share of the domain, the Irritable bowel syndrome segment dominated the market in 2022. It accrued US$ 290.89 million in 2022 and is estimated to generate US$ 639.79 million by 2028 to grow at a CAGR of 14.0% over the forecast period.

Our regional analysis states that the Rest of South & Central America captured 34.0% market share in 2022. It was assessed at US$ 252.86 million in 2022 and is likely to hit US$ 532.53 million by 2028, exhibiting a CAGR of 13.2% during the forecast period.     

Key players dominating the South & Central America colorectal procedure market are B. Braun Melsungen AG; Boston Scientific Corporation; Cardinal Health Inc.; Colospan Ltd; Ethicon (Johnson & Johnson Services, Inc.); Medtronic; Olympus Corporation; and SAFEHEAL among others.        

Below are listed few key developments by market players:

  • In year 2022, Ethicon announced the results of a new real-world study that shows its Echelon Circular Powered Stapler was associated with a 74% reduction in anastomotic leak rates and a 44% reduction in 30-day inpatient hospital readmission rates after colorectal surgery with a manual circular stapler.
  • In year 2022, Medtronic announced final findings from a randomized, international, multi-center center that confirmed the effectiveness of the GI Genius intelligent endoscopy module, which uses AI as an aid in detecting colorectal polyps during colonoscopy, potentially helping to prevent colorectal cancer.  

Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com

Download Free PDF Brochure